Welcome: Guest | Site Use Options | Register | Login |

The Next Generation in Disease Control

Awardee Story The Next Generation in Disease Control
Date: May 22, 2019
Author: Gerry Hayes
Source: Bee Culture ( click here to go to the source)

At the 2019 American Honey Producer Association (AHPA) held in Phoenix, AZ I was rewarded as usual by being able to renew old friendships and begin new ones, all the while learning more about honey bees. You all have heard me say this before but anyone who says that they know everything about honey bees is a liar. So, I am glad to learn more always and the AHPA Conv. is a wonderful place to do that.

American Foulbrood disease (AFB) is probably the most significant bacterial disease that infects Honey Bees. It can kill colonies. It is difficult to ID in its early stages from European Foulbrood (EFB) and Parasitic Mite Syndrome (PMS). Antibiotics can control the actively infective growing 'vegetative' stage of AFB. But, the AFB organism, Paenibacillus larvae, is a skilled survivor and when the infection reaches a certain stage it forms a protective 'spore' which is a kind of hard-shelled seed that is impervious to antibiotics, changes in heat and humidity, time, and even radiation. This spore can stay alive for decades waiting for the right place and conditions close to honey bee larvae to germinate and infect as an efficient opportunist. It is super tough. Antibiotic control methods we have used for decades were OK but imperfect.

Back in 2017 in the Journal of Invertebrate Pathology, there was a paper titled, "Bacteriophages as an alternative to conventional antibiotic use for the prevention or treatment of Paenibacillus larvae in honey bee hives" (https://www.sciencedirect.com/science/ article/pii/S0022201117302872) by Dr. Sandra Hope, Dept of Microbiology and Molecular Biology, Brigham Young University, (BYU).

I love serendipity. At the AHPA Convention, a person had set up a vendor table right next to where my table was set up. My shy gene is less functional the older I get so it was easy to introduce myself and ask who she was and why she was there. Let's start there;

Q) Now that I know who was there . . . nice to meet you, Dr. Hope. Let's start out and get some background (CV kind of) info to set the stage for the Great work you have done. Who are you?
A) I am a professor in the Microbiology & Molecular Biology department at BYU and I've been there for about 14½ years. I did a Master's Degree in Bioveterinary Science at Utah State University where I studied synthetic drugs designed to treat virus infections. I then did a PhD in Veterinary Science at the University of Kentucky studying virus infection and the immune system response in horses. After graduate school, I worked at the Medical School at the University of Kentucky in the Microbiology, Immunology & Molecular Genetics Department and worked on a project to make a better mouse research model to study the role of a certain white blood cell that is key in helping people fight infections. I was hired as a faculty member by BYU in 2004 to teach classes and to run a research "core" center for the College of Life Sciences, which is called the RIC facility. Being the director of the RIC is wonderful because I help many students and faculty across campus with their research projects and I have a lot of freedom to pick what I want to do in my own research as well as how much or how little research I do. I started the research project in honey bees in 2012. Considering my research history, I think it is pretty funny that I started in horses, then mice, and then bees -- it just seems like my research subjects are getting smaller and smaller over time!

Q) Ultimately BYU has not been known as a hotbed of honey bee research in the past. How come you decided to be a honey bee health researcher? And will you always be one?

A) This is a good point! In fact, I don't believe any honey bee research was done at BYU before I started my project. As I described above, my profession has always focused on viruses and the immune system. In 2009, I worked with another BYU professor to get a grant from Howard Hughes Medical Institute (HHMI) and begin a research program at BYU to study a new way to combat bacterial infections. HHMI's focus was on a bacteria related to Tuberculosis, and the HHMI grants expanded to over 100 universities in the U.S., which meant pretty tough scientific competition since we were all focused on the same bacteria.

As our grant was coming to an end, I sat down with my colleagues and I proposed we pick a new bacterial target. That's when I got a brilliant and exciting thought in my head -- I could combine my own love of honey bees with my love to do research! At the time, my colleagues didn't know that I secretly was a backyard beekeeper at home. I love bees! I love learning about and caring for them. When I told my colleagues that I wanted to do research in Paenibacillus larvae, they both looked at me and asked, "What disease does THAT cause?" In the end, the other two professors picked their own bacterial targets and I was excited to get to work on American Foulbrood.

Q)Explain to us what the title of your paper actually tells us. What is a bacteriophage? And why should we care?

A) The title of the paper is "Bacteriophages as an alternative to conventional antibiotic use for the prevention or treatment of Paenibacillus larvae in honey bee hives." The word 'bacteriophage' derives from the Greek word 'phage' which means 'to eat', so the name 'bacteriophage' literally means 'to eat bacteria'. Phages, as we like to call them, are a specific category of viruses that can only infect bacteria. Phages are completely inactive towards plants, animals, insects, and anything really, except for bacteria, and are very, very specific for the bacteria that they can kill. Because phages can infect and kill bacteria, they are being studied in greater depth as a new treatment approach to infections rather than using antibiotics to kill bacteria.

One of the most exciting parts about phage research is that the phages are so specific to the bacteria that they kill, so that phages attack a dangerous bacterium and completely ignore any other bacteria -- this means that healthy bacteria are not affected. This specificity of phages is different than antibiotics because an antibiotic typically kills bacteria in a broad sense, which means an antibiotic can kill the dangerous bacteria as well as the healthy bacteria.

The other exciting part about phage research applied to a bee disease is the very nature of phage inactivity against everything else. A phage against Paenibacillus larvae is not only organic, but is recognized by researchers as well as the FDA as completely safe for human (and bee) consumption. Phages can be given to bees anytime during the year, no veterinary regulations will be needed, and they are safe regardless of whether it is for spring feeding, during a honey flow, or at Fall feeding to prepare for Utah Winter!

Q)If what I read and understood in your paper is correct you have identified a group of these bacteriophages that can prevent or control AFB without antibiotics. is that right?

Yes. This paper nicely lays out the safety and efficacy of the phages in beehives, but I have to admit that there's a lot of research that lead up to this particular paper. For instance, just the capture and identification of the phages specific to Paenibacillus larvae has been an amazing scientific journey for me. To capture phages for the project, it took hundreds and hundreds of samples of dead bees (from healthy and infected hives) donated by beekeepers across the country, and from survey samples and from state apiarist samples -- these samples were essential for my students to do the work in the lab to try to find and then identify naturally occurring phages that were going to be useful for a treatment. After all of the sample processing, phage identification, and lots of DNA sequencing and testing in bacterial samples in the lab, my students and I were able to pick out the most potent natural killers against AFB and then plan to test those phages for the study that is presented in this research paper. This particular research paper was so exciting for me because it provides the first scientific evidence of using phages to effectively treat American Foulbrood in beehives, and the efficacy even amazed me! Prior to this paper, we had captured and tested other phages, through some amazing work of a former graduate student, Bryan Merrill. Our results of the first types of phages were moderate and more similar to using antibiotics. But after making broad changes to our approach and starting again with hundreds of bee samples to find different phages, we obtained the phages used for the new study presented in this paper, and these phages were a like a laser beam of destruction to AFB! We were able to show that the phages could reverse the damage of infection within three days and completely clear up the infection within 10 days, and recurrence was not detected at any point during the 10-month study.

In this paper, we also showed that the phages given to healthy hives that were at-risk of infection during an outbreak were able to completely prevent the spread of AFB where the transmission rate was otherwise very high. All of these results were done without using antibiotics and the results were far superior to any antibiotic treatment. In the phage treatment reported in this paper, AFB had occurred in a mid-summer outbreak so phages were given during honey flow. After phage treatment, the apiary experienced no more AFB that year, all hives produced honey, and the honey was safe to be harvested and consumed. The hives were strong in Fall and overwintered without issue and without AFB recurrence when observed the next Spring.

Q)Please take as much space and explain to us how these bacteriophages can control AFB. (Photos, diagrams whatever you have to sequentially and visually show how these work would be great)

Phage attached sideways

A) As I mentioned before, phages are a type of virus, which is why my particular scholarly training has prepared me well for research in this area. Phages look different than any other virus -- I've included an electron micrograph of some phages for you to share with the readers. The phages have an oblong head that contains DNA information, and a long, thin tail with small fibers at the end of the tail that can specifically stick to the bacterial target. In this picture, there are five phages each grabbing onto a fragment of bacterial wall (from a bacteria they had just killed). If you want to compare sizes, phages are much smaller than bacteria.

Phages kill bacteria much the same way that a cold virus kills cells inside your nose. The phage will first stick to the outside wall of the bacteria. Sometimes it will stick on the bacteria sideways until it gets a good grip, and then it stands up and injects its DNA into the inside of the bacteria. The phage DNA will take advantage of the

AFB Phages closeup.

equipment inside the bacteria to generate new phage proteins and begin assembling many, many copies of the phage. After a while, the inside of the bacteria will become quite full with newly-formed phages. The production of the phages is very energy-consuming to the bacteria and it will begin to feel pretty starved! After all, the phages are eating the insides out of the bacteria. Ultimately, the phages release proteins that destroy the wall of the bacteria so that all of the newly formed phages explode out of the dead bacteria and are now able to stick to any nearby bacteria to start the process again.

This process is obviously extremely destructive, so I know it may sound shocking that phages can be as safe to use as they are. There are several features that contribute to phage safety. First, phage DNA can only be read by the machinery inside a bacteria. This means that other types of species, such as people or plants or animals or insects, do not even have equipment that could read or use the phage DNA. If we eat a phage, it just gets digested. If a piece of phage DNA gets into one of our cells, it can't be used, so it is destroyed by the regular cellular digestive process for recycling as if it were something like cow DNA or chicken DNA (here you see that I like to use examples of foods I enjoy eating).

The next safety feature is that the tail of the phage and the fibers at the end of the tail are very bacteria-specific. The fibers cannot stick very well to unrelated bacteria, and if the fibers don't stick

Phage eruption from bacteria.

exactly right to make the phage stand up, then the phage can never inject its DNA into a bacteria. This means that the phages cannot infect unrelated bacteria such as lactobacillus or other beneficial bacteria. The fibers that bind and inject DNA, as well as the DNA sequence itself, is so customized that some phages cannot even infect and kill all the different strains of the bacteria that they target! For example, in the research lab, my students have found many phages that act like wimps. They can infect one or two versions of Paenibacillus larvae, but are completely useless when tested on other versions of the bacteria. Quite a bit of our research has been to test every phage we capture with as many strains of Paenibacillus larvae as possible. It was quite a task to find just the exact phages that could, in combination, kill every possible strain we challenged them against. Then if these phages are put with any other bacteria, they can't infect, they can't reproduce, and there is absolutely no bacteria-eating at all! I love that this specificity makes phages as safe as they are for our use, while being a silver bullet to AFB.

Q)You were at the AHPA Convention representing a company named Boodsafe. Is that your company? Do they make the bacteriophages?
A) The company making BroodSafe is called Esplin Biotechnology, LLC. This is not my company. The company was formed by the Esplin family as one of their investments. The Esplin's recently made a license agreement with Brigham Young University for one of my patents pending and the permission to grow and sell the phages captured and identified by my lab. The company also licensed a patent from the University of Nevada, Las Vegas, for phage use in beehives. I have worked in collaboration for several years with UNLV and we have multiple research publications on our DNA sequencing results from the Paenibacillus larvae phages. As part of any licensing agreement, the university requires that a company gives a certain percentage of benefits to the scientist, so it does means I have interest in the business, but I do not own or run the company. However, what scientist doesn't want their discoveries to be a success?! This is why I was at the AHPA Convention. One of my graduate students, Scott Brady, was hired by the Esplin company immediately upon graduation to help manufacture and quality control test the production of the phages. Scott was the other person at the AHPA Convention with me and he is incredibly skilled at growing phages, preparing them for packaging, and running the control test protocols to ensure that the phage product will be active as expected. The company makes big batches of phages, far more than I ever made in a research flask, so they are prepared to produce the phages for bulk sales in hopes that their investment will be a success.

Q) So there is an actual product that people can buy? How is it used?
A) The BroodSafe website now takes pre-sales orders for their first batch of phages that they are producing this month. They plan to package and make the sales official as soon as possible and keep producing phages to supply the demand from beekeepers. The company is able to sell the phages as a "feed additive", which is a specific category that the phages fi t into without restriction by the FDA. Once the batch of phages are grown, they are freeze-dried into a powder and mixed with a small amount of powdered sugar to package for sales. Even in the package, the phages will be quite concentrated, so the beekeeper can use the phages in one of two ways: 1) mix the phages with more powdered sugar and sprinkle in a hive, or 2) mix the phages right in with liquid feed to feed to the bees. The company anticipates that most keepers will simply stir the amount of powdered phages for their hives into a batch of sugar-feed since this makes it easy to feed to the bees (instead of dusting inside the hive). According to the research results, it is best to give three feedings of phages to the bees, with anywhere from three-days to three-weeks in between each feeding. It is best to give three feedings in order to provide the best chances of distribution of phages to the bees and larvae in a hive. The phages are sensitive to sunlight, so it will not be a good idea to put the phages into glass feeders that are on the outside of the hive where sun can hit them, but an in-hive trough or top-hive bucket feeder will work great.

Q) How good is it at controlling AFB. Is it a standalone and we don't need antibiotics anymore?

A) According to my experimental data, the phages are superior to antibiotics at controlling and preventing AFB. However, the Esplin company is specifically not advertising or selling the phages as a treatment, but only as a feed additive. This technicality in distribution and instructions for BroodSafe is due to the fact that the FDA already approves phages to be sold as a feed additive due to their safety as an additive. To sell the phages with labelling as a treatment or preventative for AFB, there is a lot more paperwork needed for the FDA's stamp, which will likely take years to complete. In light of the current need for managing AFB and the recent restrictions on antibiotics for a feed additive, the Esplin company did not want to delay any longer at getting phages into the hands of beekeepers. Therefore, the company decided to minimize the labelling claims to that of simply a feed additive rather than as a treatment or preventative so they could sell phages now, even though the research data supports what these phages can do.

As an approved feed additive, the beekeeper can decide when to use phages in their supplemental feed. The company (and I) highly recommend that the phages be included in the supplemental feeding in the same place where antibiotics used to be used -- for northern states, this is usually a Spring and Fall feeding, and for southern states or migratory bees, it would be prudent to include phages anytime that supplemental feeding is offered. When phages are included in the feed, the phages can be detected in the hive at a high concentration for the first day after feeding. The amount of phages gradually reduce daily until the number of phages returns to the low level that is naturally found in hives. A phage feed additive for AFB management will need to be repeated in the event of new exposure and also in the event of left-over AFB spores that are very hearty.

Because of AFB spores, it is highly unlikely that AFB will be eradicated, but the use of phages for management is far safer and less irritating to bee health than the use of antibiotics for management. Phages obviously add a level of safety to the bees, honey, and other bee-related products compared to the use of antibiotics where any bee products must be discarded if produced during an antibiotic feeding. It would be wonderful if phages could replace the use of antibiotics so that there was no need to destroy such precious products of the hive.

As for whether antibiotics are needed anymore . . . just remember, these phages are specific only to the bacteria that causes AFB. These phages cannot touch other bacteria, so they absolutely cannot help with European Foulbrood. Another aspect of phages is that bacteria do have a slow mutation rate and it is possible that over time (say 10 years), the bacteria could evolve to survive the current phages.

Q)Can it be improved?
A) The nice thing about phages is that, like bacteria, the phages can also evolve, sometimes faster than bacteria. With diligence to ongoing testing and phage selection for the BroodSafe product, effective phages should be available on an ongoing basis. Another recent improvement of the current phages is the new research data from my studies at the university showing that these phages can actually bind to AFB spores. I am currently working on a research manuscript to publish these results, so this is a bit of a sneak-peak at the science. The exciting thing about spore-binding phages is that the phages remain active and once the spore begins to germinate, the phage can infect and kill it. So in one way, phages are similar to antibiotics in that neither a phage or an antibiotic can kill a spore. In another way, phages are superior to antibiotics because the phages can wait-out the spores and are still active once the spore begins to germinate whereas an antibiotic will decay and become inactive over time. We hypothesize that the lack of recurrence of AFB in the phage-treated hives of the research paper was due to the spore-binding properties of the phages. This is an extremely exciting prospect and more research will need to be done to see just how well phage treatment can prevent recurrence and/or how phage treatment on a spore-laden object might work at preventing future infection.

Q)This is pretty cool. What's next?
A) Believe it or not, I have not decided what I want to do next! I am turning over the R&D work to the company and into the capable hands of my former graduate student, Scott Brady. I still have a few more publications (such as the spore-binding paper) to get into scientific journals before I'm done with the Paenibacillus larvae phage work at the university. I recently used the last of my grant money designated for bee research, so at this point, I need to give thought to what my next focus is and then work on some grant-writing! I have kicked around a few ideas about pursuing phages for European Foulbrood, I've had a ton of people recommend I take on the Varroa challenge, although phages can't infect insects, so I don't know what approach I'd take on that. I've had others ask me about pursuing phages for other bacterial infections in farm animals or humans. I really haven't decided anything yet, and today I just have on my mind to prepare what I need for lecture in the biology class that I'm teaching this semester.

News Bureau

Your OPPORTUNITY to upload into this extensively used SBIR-STTR Tracking system

  • Published articles about YOUR SBIR-involved firm
  • Press releases for pick-up by other sources
  • Professional papers; White papers; relevant Business materials

It is a rare issue of the major Business Press - WSJ; New York Times; Washington Post - and regional equivalents; magazines of similar importance - The Economist, Fortune, Forbes etc - and now a wealth of electronic communications and daily news feeds that does not include reference to, or articles about, one/more SBIR-STTR Awardees. With the focus usually on what the firm is about - their technical achievement or business emphasis - it is an unusual coverage that even mentions their SBIR involvement. An integral part of the extensive range of data we continuously assembled in our system on all SBIR-STTR involved firms includes this type of press coverage.  Much that we gather includes firms no longer SBIR involved or still in business, nor now eligible. ...more

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com